Home Business & Finance AstraZeneca Is Said to Have Explored Bristol Myers Merger
Business & Finance

AstraZeneca Is Said to Have Explored Bristol Myers Merger

Key Points

Aug 3rd, 2026 AstraZeneca Is Said to Have Explored Bristol Myers Merger AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It’s unclear if discussions are ongoing or whether they will result in a transaction, the people cautioned. A representative for AstraZeneca declined to comment and Bristol Myers Squibb couldn’t immediately be reached for comment on the talks.

Aug 3rd, 2026 AstraZeneca Is Said to Have Explored Bristol Myers Merger AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It’s unclear if discussions are ongoing or whether they will result in a transaction, the people cautioned. A representative for AstraZeneca declined to comment and Bristol Myers Squibb couldn’t immediately be reached for comment on the talks. Bloomberg's Manuel Baigorri reports.
AstraZeneca (ORG) Bristol Myers Squibb (ORG) Bloomberg (PERSON) Manuel Baigorri (PERSON)
Originally published by Bloomberg Markets Read original →